These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9635827)

  • 21. MET and MYC cooperate in mammary tumorigenesis.
    Welm AL; Kim S; Welm BE; Bishop JM
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4324-9. PubMed ID: 15738393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superfusion of normal and neoplastic mouse mammary tissue with estrogens.
    De Ryck LM; Raus JC
    Endocrinology; 1983 Jul; 113(1):399-408. PubMed ID: 6861710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
    Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ; Dickson RB
    Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Of mice and Myc: c-Myc and mammary tumorigenesis.
    Jamerson MH; Johnson MD; Dickson RB
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):27-37. PubMed ID: 15082916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium.
    Chepko G; Slack R; Carbott D; Khan S; Steadman L; Dickson RB
    Tissue Cell; 2005 Oct; 37(5):393-412. PubMed ID: 16137731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative growth of normal and malignant mouse mammary epithelium cultured serum-free on a biomatrix from preadipocytes.
    Shappell NW; Lazo RO; Asch BB
    In Vitro Cell Dev Biol; 1991 Jul; 27A(7):569-77. PubMed ID: 1716254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of Thy 1.2 antigen expression on the surfaces of mouse mammary epithelial cells.
    Thompson K
    J Natl Cancer Inst; 1981 Jul; 67(1):143-8. PubMed ID: 6265679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
    Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.
    Osborne MP; Bradlow HL; Wong GY; Telang NT
    J Natl Cancer Inst; 1993 Dec; 85(23):1917-20. PubMed ID: 8230281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1.
    Xie Z; Zeng X; Waldman T; Glazer RI
    Cancer Res; 2003 Sep; 63(17):5370-5. PubMed ID: 14500370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of c-myc is down-regulated as mouse mammary epithelial cells become confluent.
    Grolli S; Accornero P; Ramoni R; Donofrio G; Whitelaw CB
    Biochem Biophys Res Commun; 1997 Oct; 239(2):566-9. PubMed ID: 9344871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
    Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis.
    Mack DL; Boulanger CA; Callahan R; Smith GH
    Breast Cancer Res; 2007; 9(4):R42. PubMed ID: 17626637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
    Jäger R; Herzer U; Schenkel J; Weiher H
    Oncogene; 1997 Oct; 15(15):1787-95. PubMed ID: 9362445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predominant 4-hydroxylation of estradiol by constitutive cytochrome P450s in the female ACI rat liver.
    Wilson AM; Reed GA
    Carcinogenesis; 2001 Feb; 22(2):257-63. PubMed ID: 11181446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis.
    Jang JW; Boxer RB; Chodosh LA
    Mol Cell Biol; 2006 Nov; 26(21):8109-21. PubMed ID: 16908535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.